Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

SHA:688016 Revenue

Shanghai MicroPort Endovascular MedTech had revenue of 370.24M CNY in the quarter ending March 31, 2026, with 11.45% growth. This brings the company's revenue in the last twelve months to 1.39B, up 17.64% year-over-year. In the year 2025, Shanghai MicroPort Endovascular MedTech had annual revenue of 1.35B with 11.96% growth.

• Revenue (ttm): 1.39B
• Revenue Growth: +17.64%
• P/S Ratio: 9.05
• Revenue / Employee: 1.69M
• Employees: 822
• Market Cap: 12.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.35B	144.31M	11.96%
Dec 31, 2024	1.21B	19.12M	1.61%
Dec 31, 2023	1.19B	290.70M	32.43%
Dec 31, 2022	896.50M	211.87M	30.95%
Dec 31, 2021	684.63M	214.38M	45.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error